Edison, NJ, United States of America

Doris L Keller

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doris L Keller. Retrieved from https://idiyas.com/inventor/doris-l-keller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Doris L Keller: Innovator in Gastric Cytoprotection and Anti-inflammatory Therapies

Introduction

Doris L Keller is a prominent inventor based in Edison, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and analgesic therapies. With a total of 2 patents, her work has the potential to improve the quality of life for patients suffering from chronic conditions.

Latest Patents

Keller's latest patents include an innovative anti-inflammatory/analgesic combination that utilizes cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) in conjunction with a non-steroidal anti-inflammatory drug (NSAID). This combination has been shown to exhibit much lower gastric lesions or ulcers than those typically associated with NSAIDs, making it clinically useful for long-term therapy in patients with chronic rheumatoid arthritis or osteoarthritis. Another notable patent is for gastric cytoprotection using L-363,586, a somatostatin analog that induces gastric cytoprotection through a mechanism that does not involve the inhibition of gastric acid secretions. This compound has specific therapeutic utilities for conditions such as erosive gastritis, erosive esophagitis, inflammatory bowel disease, and ethanol-induced hemorrhagic gastric erosions.

Career Highlights

Doris L Keller is currently associated with Merck & Company, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its innovative approach to addressing common gastrointestinal issues associated with traditional anti-inflammatory medications.

Collaborations

Keller has collaborated with notable professionals in her field, including Marvin M Goldenberg, to further enhance her research initiatives and patent developments.

Conclusion

Doris L Keller's contributions to the pharmaceutical industry, particularly in the realm of gastric cytoprotection and anti-inflammatory therapies, highlight her role as an influential inventor. Her innovative patents have the potential to significantly impact patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…